NCT03055364View on ClinicalTrials.gov

Cognitive Function After Treatment of Primary CNS Malignancy

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

June 13, 2017

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions
CNS Malignancy
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03055364 - Cognitive Function After Treatment of Primary CNS Malignancy | Biotech Hunter | Biotech Hunter